CLINICAL_TRIALS
trial_result
· 2021-01-08
Clinical Trial Update: Belimumab Treatment for IgG4-related Disease [Phase 4]
Summary
Clinical trial update for belimumab in IgG4-related disease (Phase 4) with unknown status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking Union Medical College Hospital | Conditions: IgG4-related Disease | Phase 4 | Status: UNKNOWN